Stay updated on Empagliflozin US Comparative Effectiveness Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin US Comparative Effectiveness Clinical Trial page.

Latest updates to the Empagliflozin US Comparative Effectiveness Clinical Trial page
- CheckyesterdayChange DetectedRevision label updated from v3.6.2 to v3.6.3 on the page. This signals a minor update to the page version, typically including small content or metadata adjustments rather than substantive changes to study information.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page now displays Revision: v3.6.2, signaling an updated page version. The previous Revision: v3.6.0 tag has been removed and replaced by the newer revision.SummaryDifference0.1%

- Check15 days agoChange DetectedNew study record update dates were added and older dates removed, updating the study record chronology to reflect recent QC and posting activity on the study page. This indicates maintenance of the study record rather than changes to the study itself.SummaryDifference0.3%

- Check22 days agoChange DetectedAdded new navigation/help items to the study details page (How to Read a Study Record, Common Questions, How to Join a Study) and an explicit recruitment note that no longer looking for participants. The Interventions header was adjusted (Intervention/Treatment added and Intervention / Treatment removed) and the page revision updated to v3.6.0.SummaryDifference0.5%

- Check29 days agoChange DetectedThe page revision updated from v3.5.4 to v3.5.5, indicating a new site release without altering the displayed study details.SummaryDifference0.1%

- Check51 days agoChange DetectedThe revision label in the page footer now shows 'Revision: v3.5.4', replacing the previous 'Revision: v3.5.3'. This update indicates an underlying template or rendering system change rather than content changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin US Comparative Effectiveness Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin US Comparative Effectiveness Clinical Trial page.